Variant Creutzfeldt-Jakob disease

Lancet

Volumn 354, Issue 9175, 1999, Pages 317-323

  Collinge, John ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

BIOPSY; BLOOD SAMPLING; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; INCUBATION TIME; INSTRUMENT STERILIZATION; NONHUMAN; ORGAN DONOR; PRION; PRIORITY JOURNAL; REVIEW; RISK; SURGICAL INSTRUMENT; TONSIL;

EID: 0033600407     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05128-4     Document Type: Review

References (68)

1. Brown P., Cathala F., Raubertas R.F., Gajdusek D.C., Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 37:1987;895-904.
2. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genetics. 6:1997;1699-1705.
3. Collinge J., Owen F., Poulter M.et al. Prion dementia without characteristic pathology. Lancet. 336:1990;7-9.
4. Collinge J., Brown J., Hardy J.et al. Inherited prion disease with 144 base-pair gene insertion, II: clinical and pathological features. Brain. 115:1992;687-710.
5. Medori R., Tritschler H.J., LeBlanc A.et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 326:1992;444-449.
6. Collinge J., Palmer M.S., Dryden A.J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 337:1991;1441-1442.
7. Palmer M.S., Dryden A.J., Hughes J.T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 352:1991;340-342.
8. Windl O., Dempster M., Estibeiro J.P.et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet. 98:1996;259-264.
9. Baker H.E., Poulter M., Crow T.J.et al. Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet. 337:1991;1286.
10. Hsiao K., Dlouhy S.R., Farlow M.R.et al. Mutant prion proteins in Gerstmann-Sträussler-Sheinker disease with neurofibrillary tangles. Nat Genet. 1:1992;68-71.
11. Griffith J.S. Self replication and scrapie. Nature. 215:1967;1043-1044.
12. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 216:1982;136-144.
13. Jackson G.S., Hosszu L.L.P., Power A.et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science. 283:1999;1935-1937.
14. Bessen R.A., Marsh R.F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol. 66:1992;2096-2101.
15. Bessen R.A., Marsh R.F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol. 68:1994;7859-7868.
16. Collinge J., Sidle K.C.L., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 383:1996;685-690.
17. Telling G.C., Parchi P., DeArmond S.J.et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 274:1996;2079-2082.
18. Parchi P., Castellani R., Capellari S.et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 39:1996;669-680.
19. Wadsworth J.D.F., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., Collinge J.Strain-specific prion-protein conformation determined by metal ions Nat Cell Biol. 1:1999;55-59.
20. Cuillé J., Chelle P.L. La maladie dite tremblante du mouton est-elle inocuable? C R Acad Sci. 203:1936;1552-1554.
21. Hadlow W.J. Scrapie and kuru. Lancet. ii:1959;289-290.
22. Gajdusek D.C., Gibbs C.J. Jr., Alpers M.P. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature. 209:1966;794-796.
23. Gibbs C.J. Jr., Gajdusek D.C., Asher D.M.et al. Creutzfeldt-Jakob disease (spongiform dncephalopathy): transmission to the chimpanzee. Science. 161:1968;388-389.
24. Wilesmith J.W., Wells G.A., Cranwell M.P., Ryan J.B. Bovine spongiform encephalopathy: epidemiological studies. Vet Rec. 123:1988;638-644.
25. Bruce M., Chree A., McConnell I., Foster J., Pearson G., Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci. 343:1994;405-411.
26. Hill A.F., Sidle K.C.L., Joiner S.et al. Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett. 255:1998;159-162.
27. Cutlip R.C., Miller J.M., Race R.E.et al. Intracerebral transmission of scrapie to cattle. J Infect Dis. 169:1994;814-820.
28. Will R.G., Ironside J.W., Zeidler M.et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
29. Collinge J., Rossor M. A new variant of prion disease. Lancet. 347:1996;916-917.
30. Hill A.F., Desbruslais M., Joiner S., Sidle K.C.L., Gowland I., Collinge J. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
31. Bruce M.E., Will R.G., Ironside J.W.et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 389:1997;498-501.
32. Cousens S.N., Vynnycky E., Zeidler M., Will R.G., Smith P.G. Predicting the CJD epidemic in humans. Nature. 385:1997;197-198.
33. Ghani A.C., Ferguson N.M., Donnelly C.A., Hagenaars T.J., Anderson R.M. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc R Soc Lond B Biol Sci. 265:1999;23-52.
34. Alpers M.P. Epidemiology and clinical aspects of kuru. Prusiner S.B., McKinley M.P. Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. 1987;451-465 Academic Press, San Diego.
35. Klitzman R.L., Alpers M.P., Gajdusek D.C. The natural incubation period of kuru and the episodes of transmission in three clusters of patients. Neuroepidemiology. 3:1984;3-20.
36. Brown P., Preece M.A., Will R.G. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 340:1992;24-27.
37. Owen F., Poulter M., Collinge J., Crow T.J. A codon 129 polymorphism in the PRIP gene. Nucleic Acids Res. 18:1990;3103.
38. Pattison I.H. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. Gajdusek C.J., Gibbs C.J., Alpers M.P. Slow, latent and temperate virus infections, NINDB monograph 2. 1965;9-57 US Government Printing, Washington DC.
39. Wells G.A.H., Hawkins S.A.C., Green R.B.et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec. 142:1998;103-106.
40. Barlow R.M., Middleton D.J. Dietary transmission of bovine spongiform encephalopathy to mice. Vet Rec. 126:1990;111-112.
41. Prusiner S.B., Scott M., Foster D.et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 63:1990;673-686.
42. Collinge J., Palmer M.S., Sidle K.C.L.et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature. 278:1995;779-783.
43. Diringer H., Roehmel J., Beekes M. Effect of repeated oral infection of hamsters with scrapie. J Gen Virol. 79:1998;609-612.
44. Anderson R.M., Donnelly C.A., Ferguson N.M.et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature. 382:1996;779-788.
45. Collinge J., Beck J., Campbell T., Estibeiro K., Will R.G. Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet. 348:1996;56.
46. Hill A.F., Butterworth R.J., Joiner S.et al. Investigation of variant Creutzfeldt Jakob disease and other human prion disease with tonsil biopsy samples. Lancet. 353:1999;183-189.
47. Goldmann W., Hunter N., Martin T., Dawson M., Hope J. Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol. 72:1991;201-204.
48. Clouscard C., Beaudry P., Elsen J.M.et al. Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. J Gen Virol. 76:1995;2097-2101.
49. Fraser H., Bruce M.E., Davies D., Farguhar C.F., McBride P.A. The Lymphoreticular system in the pathogenesis of scrapie. Prusiner S.B., Collinge J., Powell J., Anderton B. Prion diseases of humans and animals. 1992;308-317 Ellis Horwood, London.
50. Wells G.A., Dawson M., Hawkins S.A.et al. Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec. 135:1994;40-41.
51. Hill A.F., Zeidler M., Ironside J., Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet. 349:1997;99-100.
52. Hilton D.A., Fathers E., Edwards P., Ironside J.W., Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet. 352:1998;703-704.
53. Outram G.W., Dickinson A.G., Fraser H. Reduced susceptibility to scrapie in mice after steroid administration. Nature. 9:1974;855-856.
54. Aguzzi A., Collinge J. Post-exposure prophylaxis after accidental prion inoculation. Lancet. 350:1997;1519-1520.
55. Bueler H., Raeber A., Sailer A., Fischer M., Aguzzi A., Weissmann C. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med. 1:1994;19-30.
56. Race R., Chesebro B. Scrapie infectivity found in resistant species. Nature. 392:1998;770.
57. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol. 2:1995;472-477.
58. Cashman N.R., Loertscher R., Nalbantoglu J.et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell. 61:1990;185-192.
59. Klein M.A., Frigg R., Flechsig E.et al. A crucial role for B cells in neuroinvasive scrapie. Nature. 390:1997;687-690.
60. Klein M., Frigg R., Raeber A.et al. PrP expression in B-lymphocytes is not required for prion neuroinvasion. Nat Med. 4:1998;1-5.
61. Collinge J., Hawke S. B lymphocytes in prion neuroinvasion: central or peripheral players. Nat Med. 4:1998;1369-1370.
62. Bernoulli C., Siegfried J., Baumgartner G.et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1:1977;478-479.
63. Collins S., Law M.G., Fletcher A., Boyd A., Kaldor J., Masters C.L. Surgical treatment and risk of sporadic Creutzfeldt-jakob disease: a case-control study. Lancet. 353:1999;693-697.
64. Collinge J., Palmer M.S., Sidle K.C.L.et al. Transmission of fatal familial insomnia to laboratory animals. Lancet. 346:1995;569-570.
65. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., Prusiner S.B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 250:1990;1587-1590.
66. Korth C., Stierli B., Streit P.et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
67. Hill A., Antoniou M., Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol. 80:1999;11-14.
68. Kocisko D.A., Come J.H., Priola S.A.et al. Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474.